| __timestamp | Grifols, S.A. | Iovance Biotherapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 180753000 | 2704597 |
| Thursday, January 1, 2015 | 224193000 | 15470000 |
| Friday, January 1, 2016 | 197617000 | 28037000 |
| Sunday, January 1, 2017 | 288320000 | 71615000 |
| Monday, January 1, 2018 | 240661000 | 99828000 |
| Tuesday, January 1, 2019 | 276018000 | 166023000 |
| Wednesday, January 1, 2020 | 294216000 | 201727000 |
| Friday, January 1, 2021 | 354881000 | 259039000 |
| Saturday, January 1, 2022 | 361140000 | 294781000 |
| Sunday, January 1, 2023 | 330551000 | 344077000 |
Unleashing insights
In the competitive world of biotechnology, innovation is key. Grifols, S.A. and Iovance Biotherapeutics, Inc. are two companies that have consistently invested in research and development (R&D) over the past decade. From 2014 to 2023, Grifols has shown a steady increase in R&D spending, peaking in 2022 with a 100% increase from 2014. Meanwhile, Iovance Biotherapeutics has demonstrated a more dramatic growth trajectory, with R&D expenses skyrocketing by over 12,000% during the same period. By 2023, Iovance surpassed Grifols in R&D investment, highlighting its aggressive push towards innovation. This trend underscores the dynamic nature of the biotech industry, where strategic investments in R&D can redefine market positions. As these companies continue to innovate, their commitment to R&D will likely shape the future of healthcare solutions.
Research and Development: Comparing Key Metrics for Eli Lilly and Company and Grifols, S.A.
R&D Insights: How AstraZeneca PLC and Grifols, S.A. Allocate Funds
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs Iovance Biotherapeutics, Inc.
Comparing Innovation Spending: Incyte Corporation and Iovance Biotherapeutics, Inc.
Dr. Reddy's Laboratories Limited or Iovance Biotherapeutics, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Grifols, S.A. vs Verona Pharma plc
Research and Development Expenses Breakdown: Grifols, S.A. vs TG Therapeutics, Inc.
Analyzing R&D Budgets: Grifols, S.A. vs Amicus Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Grifols, S.A. and PTC Therapeutics, Inc.
Analyzing R&D Budgets: Grifols, S.A. vs Geron Corporation
Analyzing R&D Budgets: Grifols, S.A. vs Xencor, Inc.
Geron Corporation or Iovance Biotherapeutics, Inc.: Who Invests More in Innovation?